ATRA vs VMC · rev $128.9M vs P/E 35, rev $7.42B
Atara Biotherapeutics Inc (ATRA) versus Vulcan Materials Company (VMC) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Vulcan Materials Company (VMC) is a building materials company listed on NYSE.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported VMC revenue for 2024-12-31 was $7.42B. Net income was $913.1M. Revenue was down 4.7% from 2023-12-31 to 2024-12-31. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
ATRA currently screens at market cap $87.1M. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
Not investment advice. Open the ATRA and VMC stock pages for the full models.
Not investment advice.